N-Me-L-Ala-maytansinol
N-Me-L-Ala-maytansinol is a hydrophobic, cell permeable payload used for making antibody-drug conjugate (ADC) [1].
Product Specifications
CAS Number
[77668-69-0]
UNSPSC
12352203
Target
ADC Payload
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/n-me-l-ala-maytansinol.html
Concentration
10mM
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@]12[C@H]([C@@H]([C@](O3)([H])C[C@]([C@](/C=C/C=C(C)/CC4=CC(N(C)C(C[C@]2([H])OC([C@H](C)NC)=O)=O)=C(C(OC)=C4)Cl)([H])OC)(NC3=O)O)C)O1
Molecular Formula
C32H44ClN3O9
Molecular Weight
650.16
References & Citations
[1]Nittoli T, et al. Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids. Bioorg Med Chem. 2018 May 15;26 (9) :2271-2279.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Maytansinoids
Available Sizes
Explore Other Products
Browse additional items from our catalog
TMPRSS5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
HMGCS1 (NM_001098272) Human Tagged ORF Clone Lentiviral Particle
(3β,5β,12α)-3,12-Dihydroxycholan-24-oic Acid
Recombinant Thermotoga sp. tRNA modification GTPase MnmE (mnmE)
Recombinant Thermotoga sp. tRNA modification GTPase MnmE (mnmE)
